GlobeNewsWire · NSPR · November 18, 2026
InspireMD Announces First U.S. Commercial TCAR Procedures Using the FDA-Approved CGuard® Prime TransCarotid Stent System

Get the app for more
Explore stock news, insights and company research.
Get the app → Source: GlobeNewsWire ↗